Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
69.18Prev. Close
68.03Volume
4,851Total traded value
0.03 CrUpper Circuit
69.39Lower Circuit
66.67Fundamentals
| Market Cap | ₹68Cr |
| ROE | 0.99% |
| P/E Ratio(TTM) | 158.21 |
| EPS(TTM) | 0.43 |
| P/B Ratio | 1.99 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.29 |
| Book Value | 34.11 |
| Debt to Equity | 0.50 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Concord Drugs
Concord Drugs is a pharmaceutical firm, part of a select group in India with an advanced WHO-GMP certified facility for producing high-quality products. The company's management is dedicated to achieving the highest standards of excellence through a system of total quality management in all its operations. Its core strength is providing complete, end-to-end solutions to partners using its Ready-to-Fill Pellets and Finished Pharmaceutical Formulations.;
| Parent Organisation | Concord Drugs Limited |
| Managing Director | Mr. Seelam Reddy |
| BSE Symbol | 538965 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 99.55 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.60 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.24 | ||
| Wockhardt | NA (0.00%) | -197.40 |